✦ LIBER ✦

Fludarabine, Cyclophosphamide and Rituximab: an effective chemoimmunotherapy combination with high remission rates for chronic lymphocytic leukaemia

✍ Scribed by A. Hayat; S. McGuckin; E. Conneally; P. V. Brown; S. R. McCann; M. Lawler; F. Quinn; E. Delaney; P. O’Rourke; S. Liptrot; D. O’Brien; E. Vandenberghe

Book ID: 107526250
Publisher: Springer-Verlag
Year: 2009
Tongue: English
Weight: 174 KB
Volume: 178
Category: Article
ISSN: 1863-4362
DOI: 10.1007/s11845-009-0358-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Circulating CD52 and CD20 levels at end

Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab (FCR)

✍ Gheath Alatrash; Maher Albitar; Susan O’Brien; Xuemei Wang; Taghi Manshouri; Ste 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

Mitoxantrone in combination with an inhi

Mitoxantrone in combination with an inhibitor of DNA-dependent protein kinase: a potential therapy for high risk B-cell chronic lymphocytic leukaemia

✍ Sarah L. Elliott; Clark Crawford; Evan Mulligan; Geoffrey Summerfield; Paula New 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB